Ihsan Salloum to Diagnosis, Dual (Psychiatry)
This is a "connection" page, showing publications Ihsan Salloum has written about Diagnosis, Dual (Psychiatry).
Connection Strength
0.835
-
Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Read. 2003 Aug; 13(8):375-82.
Score: 0.205
-
Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Read. 2003 Jul; 13(7):331-2, 339-41.
Score: 0.204
-
Salloum IM, Brown ES. Management of comorbid bipolar disorder and substance use disorders. Am J Drug Alcohol Abuse. 2017 07; 43(4):366-376.
Score: 0.132
-
Salloum IM, Cornelius JR, Douaihy A, Kirisci L, Daley DC, Kelly TM. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study. Addict Behav. 2005 Oct; 30(9):1702-8.
Score: 0.059
-
Salloum IM, Douaihy A, Ndimbie OK, Kirisci L. Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients. J Addict Dis. 2004; 23(2):71-81.
Score: 0.053
-
Salloum IM, Cornelius JR, Mezzich JE, Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord. 2002 Dec; 4(6):418-21.
Score: 0.049
-
Mar?n-Navarrete R, Medina-Mora ME, Horigian VE, Salloum IM, Villalobos-Gallegos L, Fern?ndez-Mondrag?n J. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use. J Dual Diagn. 2016 Jul-Dec; 12(3-4):261-270.
Score: 0.032
-
Maremmani I, Pacini M, Lamanna F, Pani PP, Perugi G, Deltito J, Salloum IM, Akiskal H. Mood stabilizers in the treatment of substance use disorders. CNS Spectr. 2010 Feb; 15(2):95-109.
Score: 0.020
-
Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. J Subst Abuse Treat. 2006 Jan; 30(1):73-7.
Score: 0.015
-
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
Score: 0.015
-
Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study. Addict Behav. 2005 May; 30(4):807-14.
Score: 0.014
-
Le Fauve CE, Litten RZ, Randall CL, Moak DH, Salloum IM, Green AI. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res. 2004 Feb; 28(2):302-12.
Score: 0.013
-
Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation. J Child Adolesc Psychopharmacol. 2004; 14(1):33-8.
Score: 0.013
-
Cornelius JR, Bukstein O, Salloum I, Clark D. Alcohol and psychiatric comorbidity. Recent Dev Alcohol. 2003; 16:361-74.
Score: 0.012